...
首页> 外文期刊>Frontiers in Pediatrics >Factors Associated With In-hospital Mortality of Children With Acute Fulminant Myocarditis on Extracorporeal Membrane Oxygenation
【24h】

Factors Associated With In-hospital Mortality of Children With Acute Fulminant Myocarditis on Extracorporeal Membrane Oxygenation

机译:与体外膜氧合急性膨胀性心肌炎的儿童中医发生相关的因素

获取原文

摘要

Abstract Aim: To analyze the factors associated with in-hospital mortality of children with acute fulminant myocarditis on venoarterial extracorporeal membrane oxygenation (VA-ECMO). Methods: This was a retrospective cohort study using chart reviews of patients diagnosed with acute fulminant myocarditis at the pediatric intensive care unit of two tertiary medical centers between January 1, 2005 and December 31, 2017. The inclusion criteria for this study were: 1) age from 1 month to 18 years; 2) diagnosed with acute myocarditis; 3) cardiogenic shock and need vasoactive-inotropic score ≧20 within 48 hours after the use of vasoactive-inotropic agents; and 4) the need for ECMO placement. Results Thirty-three children with acute fulminant myocarditis who needed ECMO were included. Clinical parameters were retrospectively reviewed. The overall survival rate was 69.6%. Higher levels of pre-ECMO troponin-I and pre-ECMO lactate, and lower post-ECMO left ventricular ejection fraction (LVEF) were significantly associated with in-hospital mortality in univariate analysis. Only higher pre-ECMO lactate and lower post-ECMO LVEF remained as predictors for in-hospital mortality in multivariate analysis. The areas under the curve of pre-ECMO lactate and post-ECMO LVEF in predicting survival were 0.84 (95% CI, 0.697-0.999, p=0.002) and 0.824 (95% CI, 0.704-0.996, p=0.02), respectively. A pre-ECMO lactate level of 79.8 mmol/L and post-ECMO LVEF of 39% were appropriate cutoff points to predict mortality. Conclusion Pre-ECMO lactate level was associated with mortality in children with acute fulminant myocarditis, with an optimal cutoff value of 79.8 mmol/L. After VA-ECMO implantation, post-ECMO LVEF was associated with mortality, with an optimal cutoff value of 39%. The use of LVADs or urgent heart transplantation should be considered if the post-ECMO LVEF does not improve.
机译:摘要目的:分析静脉内体外膜氧合(VA-ECMO)对急性膨胀心肌炎儿童的住院儿童死亡率相关的因素。方法:这是一项回顾性队列研究,使用于2017年1月1日至2017年1月1日至12月31日之间诊断出患有急性激动的心肌炎的患者的患者的临界队列研究。本研究的纳入标准是:1)年龄从1个月到18岁; 2)诊断出急性心肌炎; 3)在使用血管活性 - 辅助剂后48小时内,血管生成休克和需要血管活性型浸润性评分χ20; 4)需要ECMO安置。结果三十三个患有急性激动的心肌炎的儿童需要急性富含ECMO。回顾性审查临床参数。总生存率为69.6%。更高水平的ECMO肌钙蛋白-I和eCMO乳酸,以及降低的ECMO左心室喷射部分(LVEF)与单变量分析中的住院内死亡率显着相关。只有较高的ECMM乳酸乳酸乳酸和较低的ECMO LVEF仍然作为多变量分析中院内死亡率的预测因素。预测存活前ECMO乳酸和后ECMO的曲线下的区域分别为0.84(95%CI,0.697-0.999,P = 0.002)和0.824(95%CI,0.704-0.996,P = 0.02) 。预计79.8 mmol / L和后ECMO的乳酸乳酸乳酸水平为39%,是适当的截止点,以预测死亡率。结论ECMO前乳酸乳酸乳酸乳酸水平与急性暴发性心肌炎的儿童死亡率有关,最佳截止值为79.8 mmol / L.在VA-ECMO植入之后,ECMO后LVEF与死亡率有关,最佳截止值为39%。如果ECMO LVEF没有改善,则应考虑使用LVAD或紧急心脏移植。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号